Quadrille Capital
Quadrille Capital is an independent private investment firm based in Paris and San Francisco.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Quadrille Capital Information
Geographic Data
Address: 16, Place de la Madeleine
City: Paris
State: île-de-france
Zip: 75008
Country: FR
Financial Info
Stage:
Raised Last:
$0
Raised Total:$690M
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Quadrille Capital is an independent private investment firm based in Paris and San Francisco. They spun off from Quilvest in 2012 and manage more than €900m in information technology and healthcare. Formerly Known as Quilvest Ventures. Quadrille Capital is Paris-based private equity and venture capital firm established in 2001, investing globally in technology and energy, two industries with sustainable long term growth. Technology includes IT, internet, healthcare and cleantech. Energy includes oil services, exploration and production, midstream, power and renewables. Quadrille Capital provides access to the best-performing funds of these fields worldwide, as well as to some of these funds’ portfolios’ best companies through direct investments. Quadrille Capital also builds customized partnerships with corporate groups.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2016 | Ardelyx | Post-IPO Equity | 0 |
| 6/2015 | Coravin | Series C | 13.6M |
| 2/2020 | Hinge Health | Series C | 90M |
| 11/2016 | Coravin | Venture Round | 22.5M |
| 5/2018 | Tamara Mellon | Series B | 23.7M |
| 9/2015 | BlueJeans Network | Series E | 76.5M |
| 11/2016 | Synaptive Medical | Venture Round | - |
| 8/2015 | RDG GmbH &a; Co. KG | Private Equity Round | - |
| 3/2021 | Rohlik | Series B | 0 |
| 3/2023 | Medwing | Series C | 0 |
| 10/2022 | Homa Games | Series B | 0 |
| 9/2009 | Neotract | Series B | 28.1M |
| 7/2022 | BigHat Biosciences | Series B | 0 |
| 4/2014 | Intarcia Therapeutics | Venture Round | 0 |
| 5/2017 | Intrinsic Therapeutics | Debt Financing | 28M |
| 6/2016 | Expanse | Series A | 20M |
| 1/2014 | Neotract | Venture Round | 50.6M |
| 2/2014 | Coravin | Series B | 14M |
| 12/2021 | ezCater | Series D | 0 |
| 7/2018 | Tuya | Series C | 200M |
| 2/2005 | Frontier Silicon | Venture Round | 28M |
| 3/2007 | Amp&s;d Mobile | Venture Round | 2.7M |
| 4/2019 | Intrinsic Therapeutics | Series E | 52M |
| 3/2005 | Rakuten France | Venture Round | 0 |
| 1/2022 | PlanRadar | Series B | 0 |
| 1/2023 | Anyfin | Series C | 0 |
| 4/2019 | ezCater | Series D | 150M |
| 4/2019 | Bitglass | Series D | 70M |
| 7/2019 | NA-KD.com | Series B | 0 |
| 10/2017 | iAdvize | Series C | 37.6M |
| 12/2021 | Jobandtalent | Series E | 0 |
| 3/2007 | Intarcia Therapeutics | Venture Round | 50M |
| 4/2006 | Amp&s;d Mobile | Venture Round | 7.5M |
| 6/2019 | Tamara Mellon | Series C | 0 |
| 12/2022 | Evaneos | Venture Round | 0 |
| 9/2014 | Well-Foam | Private Equity Round | - |
| 10/2017 | Tuya | Series B | - |
| 10/2021 | Anyfin | Series B | 51.9M |
| 7/2021 | Rohlik | Series C | 0 |
| 11/2019 | Jobandtalent | Series C | 0 |
| 5/2010 | Vanksen | Series A | 5M |
| 2/2021 | Medwing | Venture Round | - |
| 12/2021 | La Belle Vie | Series B | 28.2M |
| 1/2021 | Hinge Health | Series D | 300M |
| 7/2022 | BigHat Biosciences | Series B | 0 |
| 1/2022 | PlanRadar | Series B | 0 |
| 12/2021 | La Belle Vie | Series B | 0 |
| 12/2021 | ezCater | Series D | 0 |
| 12/2021 | Jobandtalent | Series E | 0 |
| 10/2021 | Anyfin | Series B | 0 |
| 7/2021 | Rohlik | Series C | 0 |
| 3/2021 | Rohlik | Series B | 0 |
| 2/2021 | Medwing | Venture Round | - |
| 1/2021 | Hinge Health | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
